Apyx Medical Corp Earnings Per Share Disclosure
NOTE 14. EARNINGS (LOSS) PER SHARE
Basic earnings (loss) per share (“basic EPS”) is computed by dividing the net income or loss by the weighted average number of common shares outstanding for the reporting period. Diluted earnings per share (“diluted EPS”) gives effect to all dilutive potential shares outstanding. As the Company is in a net loss position for all periods presented, all potential shares outstanding are anti-dilutive. The following table provides the computation of basic and diluted loss per share.
| Year Ended | ||||||||
| December 31, | ||||||||
| (in thousands, except per share data) | 2024 | 2023 | ||||||
| Numerator: | ||||||||
| Net loss attributable to stockholders | $ | (23,463 | ) | $ | (18,713 | ) | ||
| Denominator: | ||||||||
| Weighted average shares outstanding - basic and diluted | 35,542 | 34,622 | ||||||
| Loss per share: Basic and diluted | $ | (0.66 | ) | $ | (0.54 | ) | ||
| Anti-dilutive instruments excluded from diluted loss per common share: | ||||||||
| Options | 7,638 | 7,343 | ||||||
| Warrants | 1,500 | 1,500 | ||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2024 | Mar 13, 2025 | Showing above |
| 2023 | Mar 21, 2024 | |
| 2019 | Mar 31, 2020 | |
| 2018 | Mar 14, 2019 | |
| 2017 | Mar 13, 2018 | |
| 2016 | Mar 10, 2017 | |
| 2015 | Mar 18, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.